Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura Santini

Showing results (11-20 of 47) with videos related to

Pageof 5
Sort By:
NPJ Vaccines|December 22, 2017
An efficient cell free enzyme-based total synthesis of a meningococcal vaccine candidateTimm Fiebig, Maria Rosaria Romano, Davide Oldrini, et al.
Human Vaccines & Immunotherapeutics|October 24, 2018
Evaluation of strain coverage of the multicomponent meningococcal serogroup B vaccine (4CMenB) administered in infants according to different immunisation schedulesAlessia Biolchi, Sara Tomei, Laura Santini, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|August 24, 2019
Cocrystal structure of meningococcal factor H binding protein variant 3 reveals a new crossprotective epitope recognized by human mAb 1E6Federica Bianchi, Daniele Veggi, Laura Santini, et al.
Infection and Immunity|January 1, 2014
Nonfunctional variant 3 factor H binding proteins as meningococcal vaccine candidatesStijn van der Veen, Steven Johnson, Ilse Jongerius, et al.
ACS Chemical Biology|February 27, 2018
Combined Chemical Synthesis and Tailored Enzymatic Elongation Provide Fully Synthetic and Conjugation-Ready Neisseria meningitidis Serogroup X Vaccine AntigensDavide Oldrini, Timm Fiebig, Maria Rosaria Romano, et al.
FASEB Bioadvances|August 8, 2024
Bactericidal human monoclonal antibody 1B1 shows specificity for meningococcal factor H binding protein variant 2 and displaces human factor HDaniele Veggi, Chelsy C Chesterman, Laura Santini, et al.
Journal of Molecular Biology|December 23, 2008
Epitope mapping of a bactericidal monoclonal antibody against the factor H binding protein of Neisseria meningitidisMaria Scarselli, Francesca Cantini, Laura Santini, et al.
Infection and Immunity|January 25, 2005
The region comprising amino acids 100 to 255 of Neisseria meningitidis lipoprotein GNA 1870 elicits bactericidal antibodiesMarzia Monica Giuliani, Laura Santini, Brunella Brunelli, et al.
Plos Pathogens|October 2, 2020
4CMenB vaccine induces elite cross-protective human antibodies that compete with human factor H for binding to meningococcal fHbpDaniele Veggi, Federica Bianchi, Laura Santini, et al.
Human Vaccines & Immunotherapeutics|December 16, 2020
Bactericidal antibodies against hypervirulent <i>Neisseria meningitidis</i> C field strains following MenC-CRM or MenACWY-CRM priming and MenACWY-CRM booster in childrenMarzia Monica Giuliani, Alessia Biolchi, Pavitra Keshavan, et al.
Pageof 5

Showing results (11-20 of 47) with videos related to

Sort By:
Pageof 5
NPJ Vaccines|December 22, 2017
An efficient cell free enzyme-based total synthesis of a meningococcal vaccine candidateTimm Fiebig, Maria Rosaria Romano, Davide Oldrini, et al.
Human Vaccines & Immunotherapeutics|October 24, 2018
Evaluation of strain coverage of the multicomponent meningococcal serogroup B vaccine (4CMenB) administered in infants according to different immunisation schedulesAlessia Biolchi, Sara Tomei, Laura Santini, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|August 24, 2019
Cocrystal structure of meningococcal factor H binding protein variant 3 reveals a new crossprotective epitope recognized by human mAb 1E6Federica Bianchi, Daniele Veggi, Laura Santini, et al.
Infection and Immunity|January 1, 2014
Nonfunctional variant 3 factor H binding proteins as meningococcal vaccine candidatesStijn van der Veen, Steven Johnson, Ilse Jongerius, et al.
ACS Chemical Biology|February 27, 2018
Combined Chemical Synthesis and Tailored Enzymatic Elongation Provide Fully Synthetic and Conjugation-Ready Neisseria meningitidis Serogroup X Vaccine AntigensDavide Oldrini, Timm Fiebig, Maria Rosaria Romano, et al.
FASEB Bioadvances|August 8, 2024
Bactericidal human monoclonal antibody 1B1 shows specificity for meningococcal factor H binding protein variant 2 and displaces human factor HDaniele Veggi, Chelsy C Chesterman, Laura Santini, et al.
Journal of Molecular Biology|December 23, 2008
Epitope mapping of a bactericidal monoclonal antibody against the factor H binding protein of Neisseria meningitidisMaria Scarselli, Francesca Cantini, Laura Santini, et al.
Infection and Immunity|January 25, 2005
The region comprising amino acids 100 to 255 of Neisseria meningitidis lipoprotein GNA 1870 elicits bactericidal antibodiesMarzia Monica Giuliani, Laura Santini, Brunella Brunelli, et al.
Plos Pathogens|October 2, 2020
4CMenB vaccine induces elite cross-protective human antibodies that compete with human factor H for binding to meningococcal fHbpDaniele Veggi, Federica Bianchi, Laura Santini, et al.
Human Vaccines & Immunotherapeutics|December 16, 2020
Bactericidal antibodies against hypervirulent <i>Neisseria meningitidis</i> C field strains following MenC-CRM or MenACWY-CRM priming and MenACWY-CRM booster in childrenMarzia Monica Giuliani, Alessia Biolchi, Pavitra Keshavan, et al.
Pageof 5